Der Nervenarzt

, Volume 81, Issue 8, pp 998–1002

Bericht vom 2. NeuroUpdate der MedUpdate-Reihe in Wiesbaden

Aktuelles
  • 92 Downloads

Report of the 2nd NeuroUpdate from the MedUpdate series in Wiesbaden

Literatur

  1. 1.
    Woodworth BA, Gillespie MB, Lambert PR (2004) The canalith repositioning procedure for benign positional vertigo: a meta analysis. Laryngoscope 114:1143–1146CrossRefPubMedGoogle Scholar
  2. 2.
    Newman-Toker DE, Kattah JC, Alvernia JE, Wang DZ (2008) Normal head impulse test differentiates acute cerebellar strokes from vestibular neuritis. Neurology 70:2378–2385CrossRefPubMedGoogle Scholar
  3. 3.
    Kattah JC, Talkad AV, Wang DZ et al (2009) HINTS to diagnose stroke in acute vestibular syndrome. Three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke 40:3504–3510CrossRefPubMedGoogle Scholar
  4. 4.
    Theysohn JM, Kraff O, Madenwald S et al (2009) The human hippocampus at 7T-in vivo MRI. Hippocampus19:1–7Google Scholar
  5. 5.
    Douw l, Klein M et al (2009) Cognitive and radiological effects of radiotherapy in patientens with low-grade gliome: long-term follow-up. Lancet Neurol 8:810–818CrossRefPubMedGoogle Scholar
  6. 6.
    Wick W, Weller M et al (2009) NOA-04 Randomized phase III study of sequential radiochemotherapy of anaplastic glioma with Procarbazine, Lomustine, and Vincristine or Temozolomide. J Clin Oncol 27:5874–5880CrossRefPubMedGoogle Scholar
  7. 7.
    Florance NR, Davis RL, Lam C et al (2009) Anti-N-methyl-apsartate receptor (NMDAR) encephalitis in children and adolsescents. Ann Neurol 66:11–18CrossRefPubMedGoogle Scholar
  8. 8.
    Hofmeijer J et al (2009) Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): A multicentre, open, randomised trial. Lancet Neurol 8:326–333CrossRefPubMedGoogle Scholar
  9. 9.
    Molyneux AJ et al (2009) Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol 8:427–433CrossRefPubMedGoogle Scholar
  10. 10.
    Schnakers C et al (2009) Diagnostic accuracy of the vegetative and minimally conscious state: clinical consensus versus standardized neurobehavioral assessment. BMC Neurol 9:35CrossRefPubMedGoogle Scholar
  11. 11.
    Wenning W, Haghikia A, Laubenberger J et al (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075–1080CrossRefPubMedGoogle Scholar
  12. 12.
    Major EO (2009) Reemergence of PML in Natalizumab-Treated Patients – New cases, some concerns. N Engl J Med 361:1041–1043CrossRefPubMedGoogle Scholar
  13. 13.
    Giovannoni G, Comi G, Cook S et al (2010) A Placebo-controlled trial of oral Cladribine for relapsinf multiple sclerosis. NEJM 362:416–426CrossRefPubMedGoogle Scholar
  14. 14.
    Cohen J, Pelletier J, Kappos L et al (2009) Oral Fingolimod (FTY720) versus Interferon Beta 1a in rrMS: results from a phase III study (TRANSFORMS). Neurology 72:21004 (AAN 2009)Google Scholar
  15. 15.
    Bielekova B, Howard T, Packer A et al (2009) Effect of Anti-CD25 antibody daclizumab in the inhibition of infalmmation and stabilization of disease progression an multiple sclerosis. Arch Neurol 66:483–489CrossRefPubMedGoogle Scholar
  16. 16.
    Goodman AD, Brown TR, Krupp LB et al (2009) Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 373:732–738CrossRefPubMedGoogle Scholar
  17. 17.
    Beek D van de, Farrar JJ, Gans J de et al (2010) Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 9:254–263CrossRefPubMedGoogle Scholar
  18. 18.
    Pal D, Bhattacharyya A, Husain M et al (2010) In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases. AJNR Am J Neuroradiol 31:360–366CrossRefPubMedGoogle Scholar
  19. 19.
    Smith SJ, Ughratdar I, MacArthur DC (2009) Never go to sleep on undrained pus: a retrospective review of surgery for intraparenchymal cerebral abscess. Br J Neurosurg 23:412–417CrossRefPubMedGoogle Scholar
  20. 20.
    Senel M, Rupprecht TA, Tumani H et al (2009) The chemokine CXCL13 in acute neuroborreliosis. J Neurol Neurosurg Psychiatry (Epub ahead of print)Google Scholar
  21. 21.
    Eippert F, Bingel U, Schoell ED et al (2009) Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63:533–543CrossRefPubMedGoogle Scholar
  22. 22.
    Connor KM, Shapiro RE, Diener HC et al (2009) Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology 73:970–977CrossRefPubMedGoogle Scholar
  23. 23.
    Tait MJ, Levy J, Nowell M et al (2009) Improved outcome after lumbar microdiscectomy in patients shown their excised disc fragments: a prospective, double blind, randomised, controlled trial. J Neurol Neurosurg.Psychiatry 80:1044–1046Google Scholar
  24. 24.
    Morris Z, Whiteley W, Longstreth W et al (2009) Incidental findings on brain magnetic resonance imaging: systemic review and meta-analysis. BMJ 339:3016CrossRefGoogle Scholar
  25. 25.
    Choi DS, Kim MC, Lee SK et al (2009) Clinical and angiographic long term follow-up of completely coiled intracranial aneurysms using endovascular technique. J Neurosurg (Epub ahead of print)Google Scholar
  26. 26.
    Vargas MI, Delavelle J, Jlassi H et al (2008) Clinical applications of diffusion tensor tractography of the spinal cord. Neuroradiology 50:25–29CrossRefPubMedGoogle Scholar
  27. 27.
    Gladstone DJ, Rodan LH, Sahlas DJ et al (2009) A citywide prehospital protocol increases access to stroke thrombolysis in Toronto. Stroke 40:3841–3844CrossRefPubMedGoogle Scholar
  28. 28.
    Saposnik G, Kapral MK, Coutts SB et al (2009) Do all age groups benefit from organized inpatient stroke care? Stroke 40:3321–3327CrossRefPubMedGoogle Scholar
  29. 29.
    Winkler DT, Fluri F, Fuhr P et al (2009) Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome. Stroke 40:1522–1525CrossRefPubMedGoogle Scholar
  30. 30.
    Verdon V, Schwartz S, Lovblad KO et al (2009) Neuroanatomy of hemispatial neglect and its functional components: a study using voxel-based lesion-symptom mapping. Brain doi:10.1093/brain/awp305Google Scholar
  31. 31.
    Olanow CW, Rascol O, Hauser R et al (2009) A double-blind, delayed-start trial of rasagiline in Parkinson’s disease. N Engl J Med 361:1268–1278CrossRefPubMedGoogle Scholar
  32. 32.
    Voon V, Krack P, Lang AE et al (2009) Parkinson’s disease, DBS and suicide: a role for serotonin? BrainGoogle Scholar
  33. 33.
    Prokakis C, Koletsis E, Salakou S et al (2009) Modified maximal thymectomy for myasthenia gravis: effect of maximal resection on late neurologic outcome and predictors of disease remission. Ann Thorac Surg 88:1638–1646CrossRefPubMedGoogle Scholar
  34. 34.
    Mulders SAM, Broek WJAA van den, Wheeler TM et al (2009) Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. PNAS 106 (33):13915–13920CrossRefPubMedGoogle Scholar
  35. 35.
    Dalakas MC, Rakocevic G, Schmidt J et al (2009) Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis. J Neurol 132:1536–1544Google Scholar
  36. 36.
    Rabkin JG, Gordon PH, Mcelhiney M et al (2009) Modafinal treatment of fatigue in patients with ALS: A placebo-controlled study. Muscle Nerve 39:297–303CrossRefPubMedGoogle Scholar
  37. 37.
    Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:1665CrossRefGoogle Scholar
  38. 38.
    O’Donoghue ML, Braunwald E, Antman EM et al (2009) Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 374:989–997CrossRefGoogle Scholar
  39. 39.
    Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151CrossRefPubMedGoogle Scholar
  40. 40.
    Milionis HJ, Giannopoulos S, Kosmidou M et al (2009) Statin therapy after first stroke reduces 10-year stroke recurrence and improves survival. Neurology 72:1816–1822CrossRefPubMedGoogle Scholar
  41. 41.
    Brown M (2009) The results of the ICSS (International Carotid Stenting Study). ESCGoogle Scholar
  42. 42.
    Almekhlafi MA, Wilton SB, Rabi DM et al (2009) Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology 73:89–97CrossRefPubMedGoogle Scholar
  43. 43.
    Amarenco P, Goldstein LB, Messig M et al (2009) Relative and cumulative effects of lipid and blood pressure control in the stroke prevention by aggressive reduction in cholesterol levels trial. Stroke 40:2486–2492CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Neurologischen Klinik der Dr. Horst Schmidt Klinik GmbH WiesbadenWiesbadenDeutschland
  2. 2.Klinik für Neurologie Klinikum Großhadern, Ludwig-Maximilians-UniversitätMünchenDeutschland

Personalised recommendations